Pilot Trial of Neoadjuvant Sunitinib in Patients With Bulky GIST.

Trial Profile

Pilot Trial of Neoadjuvant Sunitinib in Patients With Bulky GIST.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Apr 2016 Status changed from active, no longer recruiting to discontinued.
    • 24 Sep 2013 Planned end date changed from 1 May 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.
    • 17 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top